About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Hematology and Oncology
›
Top Articles
Journal of Hematology and Oncology
Hematology
,
Oncology
,
Biology
,
Molecular Biology
22.4
(top 1%)
Impact Factor
23.7
(top 1%)
extended IF
115
(top 3%)
H-Index
1.6K
authors
1.6K
papers
63.8K
citations
3.6K
citing journals
45K
citing authors
Most Cited Articles of Journal of Hematology and Oncology
Title
Year
Citations
The effects of beta-glucan on human immune and cancer cells
2009
498
Exosomes in cancer: small particle, big player
2015
475
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers
2013
446
The biology and role of CD44 in cancer progression: therapeutic implications
2018
432
Tumor-associated macrophages: from basic research to clinical application
2017
398
Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma
2015
380
Next generation of immune checkpoint therapy in cancer: new developments and challenges
2018
375
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
2019
375
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
2019
330
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
2010
327
Clinical applications of mesenchymal stem cells
2012
317
Long non-coding RNA: a new player in cancer
2013
313
Mechanism of action of lenalidomide in hematological malignancies
2009
299
Functions of lncRNA HOTAIR in lung cancer
2014
265
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
2020
265
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
2019
262
Wnt/beta-catenin pathway: modulating anticancer immune response
2017
257
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
2019
256
Diverse functions of miR-125 family in different cell contexts
2013
255
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
2018
252
Targeting mTOR for cancer therapy
2019
245
A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
2013
230
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
2018
224
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
2016
221
An evolving new paradigm: endothelial cells--conditional innate immune cells
2013
219
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.